Pediatric palliative care in Canada in 2012: a cross-sectional descriptive study

Kimberley Widger1, Dawn Davies1, Adam Rapoport1

  • 1Lawrence S. Bloomberg Faculty of Nursing (Widger), University of Toronto; The Hospital for Sick Children (Widger, Rapoport), Toronto, Ont.; John Dossetor Health Ethics Centre (Davies), University of Alberta; Stollery Children's Hospital (Davies), Edmonton, Alta.; Departments of Paediatrics and of Family & Community Medicine (Rapoport), University of Toronto, Toronto, Ont.; Children's Hospital of Eastern Ontario (Vadeboncoeur), Ottawa, Ont.; Montreal Children's Hospital, McGill University Health Centre (Liben), Montréal, Que.; Children's Hospital London Health Sciences Centre (Sarpal), London, Ont.; Winnipeg Regional Health Authority (Stenekes), Winnipeg, Man.; Centre hospitalier universitaire de Sherbrooke (Cyr), Sherbrooke, Que.; Centre hospitalier universitaire Sainte-Justine (Daoust), Montréal, Que.; IWK Health Centre (Grégoire), Halifax, NS; University of Calgary (Robertson); Rotary/Flames House (Robertson), Calgary, Alta.; University of Saskatchewan; Royal University Hospital (Hodgson-Viden), Saskatoon, Sask.; Centre hospitalier universitaire de Québec (Laflamme), Québec, Que.; Child & Family Research Institute (Siden); Canuck Place Children's Hospice (Siden), Vancouver, BC.

CMAJ Open
|December 27, 2016
PubMed
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...